Treatment Restoration for Emergency Antibody Therapeutics Act or the TREAT Act This bill prohibits the Department of Health and Human Services (HHS) from implementing any policy that restricts health care facilities from ordering and receiving COVID-19 monoclonal antibody therapies directly from manufacturers and distributors. In addition, the bill expressly nullifies a policy announced on September 13, 2021, under which HHS allocated supplies of these therapies through state or territorial governments.
Cardiovascular and respiratory healthDrug therapyEmergency medical services and trauma careHealth care coverage and accessHealth facilities and institutionsHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesState and local government operations
TREAT Act
USA117th CongressS-2866| Senate
| Updated: 9/28/2021
Treatment Restoration for Emergency Antibody Therapeutics Act or the TREAT Act This bill prohibits the Department of Health and Human Services (HHS) from implementing any policy that restricts health care facilities from ordering and receiving COVID-19 monoclonal antibody therapies directly from manufacturers and distributors. In addition, the bill expressly nullifies a policy announced on September 13, 2021, under which HHS allocated supplies of these therapies through state or territorial governments.
Cardiovascular and respiratory healthDrug therapyEmergency medical services and trauma careHealth care coverage and accessHealth facilities and institutionsHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesState and local government operations